|
Necrotizing fasciitis
|
Determination of emm type for Streptococcus pyogenes by PCR
|
Streptococcus pyogenes
|
Streptococcus and STI Section
|
|
Necrotizing fasciitis
|
Antimicrobial Susceptibility Testing
|
Streptococcus pyogenes
|
Streptococcus and STI Section
|
|
Necrotizing pneumonia
|
Whole Genome Sequencing (WGS) **Review patient criteria
|
Staphylococcus aureus
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Necrotizing pneumonia
|
VISA/hVISA Confirmation
|
Staphylococcus aureus
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Necrotizing pneumonia
|
Confirmation
|
Methicillin-resistant Staphylococcus aureus (MRSA)
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Necrotizing pneumonia
|
Antimicrobial Susceptibility Testing
|
Staphylococcus aureus
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Necrotizing pneumonia
|
Confirmation of Staphylococcal toxins by PCR
|
Staphylococcus aureus
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Necrotizing pneumonia
|
Spa Typing
|
Methicillin-resistant Staphylococcus aureus (MRSA)
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Neonatal infections
|
Antimicrobial Susceptibility Testing
|
Streptococcus agalactiae
|
Streptococcus and STI Section
|
|
Neonatal infections
|
Serotype determination for Streptococcus agalactiae (Group B Streptococcus)
|
Streptococcus agalactiae
|
Streptococcus and STI Section
|
|
Neonatal meningitis
|
Toxin detection
|
Escherichia coli
|
Division of Enteric Diseases
|
|
Neonatal meningitis
|
Genomic subtyping
|
Escherichia coli
|
PulseNet Canada
|
|
Neonatal meningitis
|
Serotyping
|
Escherichia coli
|
Division of Enteric Diseases
|
|
Neonatal meningitis
|
Identification
|
Escherichia coli
|
Division of Enteric Diseases
|
|
Neonatal meningitis
|
Virulence Gene Detection
|
Escherichia coli
|
Division of Enteric Diseases
|
